In the last 12 months, insiders at CITIUS ONCOLOGY, INC. ($CTOR) filed 55 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
CITIUS ONCOLOGY, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- MCGRATH DENNIS M (Director) — 5 transactions totaling $0
- HOLUBIAK MYRON Z (Director) — 2 transactions totaling $0
- Dutia Suren G (Director) — 5 transactions totaling $0
- Holuka Eugene Myron (Director) — 5 transactions totaling $0
- Smith Robert Joseph (Director) — 4 transactions totaling $0
View all SEC Filings for CITIUS ONCOLOGY, INC. (CTOR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | Webb Carol | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Holuka Eugene Myron | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Dutia Suren G | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Mayersohn Joel David | Director | A | Common Stock | 300000 | $0.00 | 321,228.0000 | 71,552,402 | 1413.23% | 0.42% |
| Sept. 19, 2025 | MCGRATH DENNIS M | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Smith Robert Joseph | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Mazur Leonard L | Chief Executive Officer | A | Common Stock | 1700000 | $0.00 | 1,700,000.0000 | 71,552,402 | 9999.99% | 2.38% |
| Sept. 19, 2025 | Czuczman Myron | Chief Medical Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | Bartushak Jaime | Chief Financial Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 850000 | $0.00 | 850,000.0000 | 71,552,402 | 9999.99% | 1.19% |
| Sept. 19, 2025 | Holuka Eugene Myron | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Czuczman Myron | Chief Medical Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | Mazur Leonard L | Chief Executive Officer | A | Common Stock | 1700000 | $0.00 | 1,700,000.0000 | 71,552,402 | 9999.99% | 2.38% |
| Sept. 19, 2025 | Dutia Suren G | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Smith Robert Joseph | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 850000 | $0.00 | 850,000.0000 | 71,552,402 | 9999.99% | 1.19% |
| Sept. 19, 2025 | Bartushak Jaime | Chief Financial Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | MCGRATH DENNIS M | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Webb Carol | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Mayersohn Joel David | Director | A | Common Stock | 300000 | $0.00 | 321,228.0000 | 71,552,402 | 1413.23% | 0.42% |
| Sept. 19, 2025 | Holuka Eugene Myron | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 850000 | $0.00 | 950,000.0000 | 71,552,402 | 850.00% | 1.19% |
| Sept. 19, 2025 | HOLUBIAK MYRON Z | Secretary | A | Common Stock | 100000 | $0.00 | 950,000.0000 | 71,552,402 | 11.76% | 0.14% |
| Sept. 19, 2025 | Smith Robert Joseph | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Mazur Leonard L | Chief Executive Officer | A | Common Stock | 1700000 | $0.00 | 1,700,000.0000 | 71,552,402 | 9999.99% | 2.38% |
| Sept. 19, 2025 | Webb Carol | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Czuczman Myron | Chief Medical Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | MCGRATH DENNIS M | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | Bartushak Jaime | Chief Financial Officer | A | Common Stock | 825000 | $0.00 | 825,000.0000 | 71,552,402 | 9999.99% | 1.15% |
| Sept. 19, 2025 | Mayersohn Joel David | Director | A | Common Stock | 300000 | $0.00 | 321,228.0000 | 71,552,402 | 1413.23% | 0.42% |
| Sept. 19, 2025 | Dutia Suren G | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| July 28, 2025 | Mayersohn Joel David | Director | J | Common Stock | 21228 | $0.00 | 21,228.0000 | 71,552,402 | 9999.99% | 0.03% |
| Dec. 12, 2024 | MCGRATH DENNIS M | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 275,000.0000 | 68,053,607 | 83.33% | 0.18% |
| Dec. 12, 2024 | Dutia Suren G | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 275,000.0000 | 68,053,607 | 83.33% | 0.18% |
| Dec. 12, 2024 | Webb Carol | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 275,000.0000 | 68,053,607 | 83.33% | 0.18% |
| Dec. 12, 2024 | Smith Robert Joseph | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 68,053,607 | 9999.99% | 0.18% |
| Dec. 12, 2024 | HOLUBIAK MYRON Z | Secretary | A | Stock Option (Right to Buy) | 50000 | $0.00 | 1,850,000.0000 | 68,053,607 | 2.78% | 0.07% |
| Dec. 12, 2024 | HOLUBIAK MYRON Z | Secretary | A | Stock Option (Right to Buy) | 300000 | $0.00 | 1,850,000.0000 | 68,053,607 | 19.35% | 0.44% |
| Dec. 12, 2024 | Holuka Eugene Myron | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 275,000.0000 | 68,053,607 | 83.33% | 0.18% |
| Dec. 12, 2024 | Mayersohn Joel David | Director | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 68,053,607 | 9999.99% | 0.37% |
| Dec. 12, 2024 | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 1,800,000.0000 | 68,053,607 | 28.57% | 0.59% |
| Dec. 12, 2024 | Czuczman Myron | Chief Medical Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 1,800,000.0000 | 68,053,607 | 28.57% | 0.59% |
| Dec. 12, 2024 | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Buy) | 800000 | $0.00 | 4,500,000.0000 | 68,053,607 | 21.62% | 1.18% |
| Aug. 12, 2024 | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Buy) | 3700000 | $0.00 | 3,700,000.0000 | 67,500,000 | 9999.99% | 5.48% |
| Aug. 12, 2024 | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Buy) | 1400000 | $0.00 | 1,400,000.0000 | 67,500,000 | 9999.99% | 2.07% |
| Aug. 12, 2024 | Czuczman Myron | Chief Medical Officer | A | Stock Option (Right to Buy) | 1400000 | $0.00 | 1,400,000.0000 | 67,500,000 | 9999.99% | 2.07% |
| Aug. 12, 2024 | HOLUBIAK MYRON Z | Director | A | Stock Option (Right to Buy) | 1500000 | $0.00 | 1,500,000.0000 | 67,500,000 | 9999.99% | 2.22% |
| Aug. 12, 2024 | Holuka Eugene Myron | Director | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 67,500,000 | 9999.99% | 0.22% |
| Aug. 12, 2024 | Czuczman Myron | Chief Medical Officer | A | Stock Option (Right to Buy) | 466667 | $0.00 | 466,667.0000 | 67,500,000 | 9999.99% | 0.69% |
| Aug. 12, 2024 | Bartushak Jaime | Chief Financial Officer | A | Stock Option (Right to Buy) | 466667 | $0.00 | 466,667.0000 | 67,500,000 | 9999.99% | 0.69% |
| Aug. 12, 2024 | Mazur Leonard L | Chief Executive Officer | A | Stock Option (Right to Buy) | 1233333 | $0.00 | 1,233,333.0000 | 67,500,000 | 9999.99% | 1.83% |
| Aug. 12, 2024 | HOLUBIAK MYRON Z | Director | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 67,500,000 | 9999.99% | 0.74% |
| Aug. 12, 2024 | Webb Carol | Director | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 67,500,000 | 9999.99% | 0.22% |
| Aug. 12, 2024 | MCGRATH DENNIS M | Director | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 67,500,000 | 9999.99% | 0.22% |
| Aug. 12, 2024 | Dutia Suren G | Director | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 67,500,000 | 9999.99% | 0.22% |